Clinical Trials

NCT02756897 | ACTIVE_NOT_RECRUITING | PHASE2
234 participants

Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2016-07-07
Completion:
2027-07-01
Conditions
  • Chronic Lymphocytic Leukemia
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Small Lymphocytic Lymphoma
  • Small Lymphocytic Lymphoma
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT01989585 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
75 participants

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2014-03-24
Completion:
2027-12-31
Conditions
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Malignant Solid Neoplasm
  • Metastatic Melanoma
  • Unresectable Melanoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT01889381 | RECRUITING | PHASE2
15 participants

Human Craniomaxillofacial Allotransplantation

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2012-08-31
Completion:
2026-08-31
Conditions
  • Facial Injuries
  • Traumatic Wounds and Injuries
  • Craniofacial Injuries
  • Craniofacial Defects
  • Facial Transplantation
  • Facial Deformity
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page